Vivani Medical Expands Board, Appoints Pharma Veteran Bradbury
Company Announcements

Vivani Medical Expands Board, Appoints Pharma Veteran Bradbury

An announcement from Vivani Medical (VANI) is now available.

Vivani Medical, Inc. has expanded its Board of Directors from five to six members and appointed Daniel Bradbury to fill the new position. Bradbury brings extensive experience to the board, including his previous role as CEO of Amylin Pharmaceuticals until its acquisition by Bristol-Myers Squibb, and his current involvement with several other biopharmaceutical companies and nonprofit organizations. He will serve on the Board and the Audit Committee until the 2025 annual stockholders’ meeting, receiving compensation in line with the company’s policy for non-employee directors.

For detailed information about VANI stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskVivani Medical Reports Q3 Loss, Advances GLP-1 Trials
TipRanks Auto-Generated NewsdeskVivani Medical Secures Funding for GLP-1 Implant Trial
Ryan AdistVANI Upcoming Earnings Report: What to Expect?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App